MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas

Journal article

Peer reviewed

J. Chan, T. Kiet, A. Sherman, K. Fuh, S. Ueda, R. Brooks, D. Kapp, L. Chen and B. Monk

Gynecologic oncology, Vol.120, pp.S4-S5

03/01/2011

Metrics

6 Record Views

Title: MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas
Creators: J. Chan - UCSF Helen Diller Family Comprehensive Cancer Center
T. Kiet - UCSF Helen Diller Family Comprehensive Cancer Center
A. Sherman - UCSF Helen Diller Family Comprehensive Cancer Center
K. Fuh - UCSF Helen Diller Family Comprehensive Cancer Center
S. Ueda - UCSF Helen Diller Family Comprehensive Cancer Center
R. Brooks - UCSF Helen Diller Family Comprehensive Cancer Center
D. Kapp - Stanford Medicine
L. Chen - UCSF Helen Diller Family Comprehensive Cancer Center
B. Monk - Creighton University
Publication Details: Gynecologic oncology, Vol.120, pp.S4-S5
Publisher: Elsevier Inc
Identifiers: 991005969014402656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article